Prognostic factors in multiple myeloma:* The M.D. Anderson experience
- 24 April 2009
- journal article
- Published by Wiley in European Journal of Haematology
- Vol. 43 (S51) , 84-87
- https://doi.org/10.1111/j.1600-0609.1989.tb01498.x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Plasma cell myeloma--new biological insights and advances in therapyBlood, 1989
- Prognostic factors with high-dose melphalan for refractory multiple myeloma [see comments]Blood, 1988
- The Molecular Genetics of Philadelphia Chromosome–Positive LeukemiasNew England Journal of Medicine, 1988
- Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomasNature, 1988
- Plasma cell karyotype in multiple myelomaBlood, 1988
- High-dose chemoradiotherapy and autologous bone marrow transplantation for resistant multiple myelomaBlood, 1987
- High-Dose Glucocorticoid Treatment of Resistant MyelomaAnnals of Internal Medicine, 1986
- Prognostic implications of tumor cell DNA and RNA content in multiple myelomaBlood, 1985
- Effective Treatment of Advanced Multiple Myeloma Refractory to Alkylating AgentsNew England Journal of Medicine, 1984
- A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survivalCancer, 1975